Also trades as: IMU.AX (ASX) · $vol 0M
IUGNF OTC
Imugene Limited
1W: -28.6%
1M: -50.0%
3M: -58.4%
YTD: -90.7%
1Y: -87.2%
3Y: -98.2%
5Y: -99.8%
$0.02
-0.00 (-10.75%)
Weekly Expected Move ±41.4%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
-100.0% ▼
Gross Profit
-$7M
-255.4% ▼
Operating Income
-$75M
-5.5% ▼
Net Income
-$105M
-52.4% ▼
EPS (Diluted)
$-0.32
+0.0% ▲
EBITDA
-$68M
-0.9% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $13M | $12M | $5M | $4M | $0 |
| YoY Growth | +79.3% | -9.2% | -57.8% | -11.5% | -100.0% |
| Cost of Revenue | $2M | $2M | $6M | $0 | $7M |
| Gross Profit | $11M | $10M | $5M | $4M | -$7M |
| Gross Margin | 81.4% | 81.3% | 100.0% | 100.0% | — |
| R&D Expenses | $37M | $31M | $87M | $47M | $51M |
| SG&A Expenses | $12M | $18M | $60M | $28M | $17M |
| Operating Expenses | $51M | $51M | $159M | $75M | $68M |
| Operating Income | -$38M | -$40M | -$154M | -$71M | -$75M |
| Operating Margin | -292.5% | -337.6% | -3092.9% | -1613.5% | — |
| Interest Expense | $14K | $27K | $478K | $0 | $125K |
| Income Before Tax | -$38M | -$38M | -$154M | -$69M | -$107M |
| Tax Expense | -$13M | -$12M | -$5M | $0 | -$2M |
| Net Income | -$38M | -$38M | -$150M | -$69M | -$105M |
| Net Margin | -292.0% | -321.9% | -3011.7% | -1569.8% | — |
| EPS (Diluted) | $-0.23 | $-0.21 | $-0.72 | $-0.32 | $-0.32 |
| EBITDA | -$35M | -$47M | -$148M | -$67M | -$68M |
| Shares Outstanding | 166M | 185M | 208M | 219M | 326M |